Catalyst Wire Dossier Catalyst Wire Dossier

Olinvo

oliceridine · Trevena, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olinvo, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia [NA]

See pricing